# Silexion Therapeutics Corp (SLXNW) — capital_raise/atm_program [announced]
Source: sec.gov · situation sit_5eab54e1f4dca0616cef · public 4231353067072490725 · retrieved 2026-08-20T12:36:05.015Z

## Overview
Silexion Therapeutics Corp (formerly Biomotion Sciences) is a biological products company incorporated in the Cayman Islands.

On June 22, 2026, Moringa Sponsor, LP filed a claim against Silexion Therapeutics Corp and two senior officers, alleging deliberate and systematic breaches of an Amended and Restated Promissory Note dated August 15, 2024 (original principal amount $3.4 million). The claim challenges multiple purported conversions of debt into ordinary shares occurring between September 15, 2025 and August 12, 2026, totaling approximately $3.1 million converted into 1,391,790 ordinary shares. Moringa Sponsor seeks a declaration that the conversions are void, a determination that an Event of Default has occurred entitling it to immediate repayment of the entire outstanding debt, and alternatively, an order correcting the conversions and awarding damages.

## Terms
- Counterparty: Silexion Therapeutics Corp · Deal value: $3.4M · Consideration: mixed

## Key dates
- Announced 2026-08-20

## Timeline
- 2026-08-20 · SCHEDULE 13D/A (0001213900-26-091845): SCHEDULE 13D/A - Silexion Therapeutics Corp — *Silexion Therapeutics Corp (formerly Biomotion Sciences) is a biological products company incorporated in the Cayman Islands.* On June 22, 2026, Moringa Sponsor, LP filed a claim against Silexion Therapeutics Corp and two senior officers, alleging deliberate and systematic breaches of an Amended and Restated Promissory Note dated August 15, 2024 (original principal amount $3.4 million). The claim challenges multiple purported conversions of debt into ordinary shares occurring between September 15, 2025 and August 12, 2026, totaling approximately $3.1 million converted into 1,391,790 ordinary shares. Moringa Sponsor seeks a declaration that the conversions are void, a determination that an Event of Default has occurred entitling it to immediate repayment of the entire outstanding debt, and alternatively, an order correcting the conversions and awarding damages.
  https://www.sec.gov/Archives/edgar/data/2022416/0001213900-26-091845.txt

## Citations
- 0001213900-26-091845 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026091845